"For instance, based on the market conditions, prices of many vaccines in the private market including our pneumococcal vaccine are sold at a higher free-economy price, whereas for the government it is almost one-third of the free market price," SII said. "There was an inaccurate comparison done between the global prices of the vaccine with India," SII said. "Covisheld is the most affordable Covid-19 vaccine available in the market today," it added. The initial supply price of Covishield for all government immunisation programme, including India, has been the lowest," the statement reads. Furthermore, in the interest of public health, it is important for the market to open-up for other vaccines from across the world.

Source: dna April 24, 2021 13:41 UTC